Public health guidance has long treated walking as one habit with one target: 150 minutes a week of moderate activity, “such as brisk walking,” in the US Centers for Disease Control and Prevention’s phrasing. How much work the word brisk is doing in that sentence has stayed open — particularly for the oldest walkers, the people for whom a stroll and a workout can look nearly identical from across the room.

A cluster-randomised trial published in PLOS ONE on 30 September 2026 is the most direct test of that question in this group so far. Rather than comparing walking with not walking, it compared two walking intensities head to head — high-intensity walking against casual-speed walking, over 16 weeks, in prefrail and frail adults whose average age was 79.

What the trial did

Fourteen retirement communities were randomised to one of the two programmes. The 165 people recruited were all 60 or older and able to walk at least 10 feet with moderate assistance or less. They walked in supervised sessions of 45 minutes, three times a week, for 16 weeks. The high-intensity group was directed to walk at 70% of maximum heart rate; the casual-speed group walked at self-selected paces below 60%. Neither the participants nor the assessors knew which programme a given community had been assigned.

The primary outcome was a shift of at least one category on the SHARE-FI, a frailty index developed for European ageing research. Investigators also measured walking speed, distance covered in six minutes, balance and chair-stand performance. Of the 165 people enrolled, 105 were included in the analytic cohort.

What it found

Improvement in frailty category occurred in 32 of 46 high-intensity participants (69.6%) against 26 of 56 casual-speed participants (46.4%) — an odds ratio of 2.91, with a 95% confidence interval of 1.19 to 7.13 (p = 0.02). The high-intensity group also gained more walking speed, a mean difference of 0.08 metres per second (0.03 to 0.13), and covered roughly 49 metres more in the six-minute walk test (21.1 to 76.9).

The intensity difference was real rather than nominal. Mean effort reached 71% of maximum heart rate in the high-intensity group and 59% in the casual group. Nor was this an attendance effect: the median number of completed sessions was 35 and 36 respectively, a difference the authors did not find statistically meaningful.

The casual group improved too

The 46.4% figure is worth sitting with. Both arms were active programmes with supervision, structure, a group setting and a fixed weekly slot, and both produced frailty improvements in a substantial minority of participants. What the trial shows is that walking harder produced more improvement than walking easily. It does not show that easy walking achieves nothing, and the authors do not claim that it does.

The limits are as narrow as the population

The result comes from 105 people with a mean age of 79.2 years, 79% of them women and 75% non-Hispanic White, living in retirement communities in one country, walking under staff supervision three times a week in a fixed 45-minute slot. About a quarter of those enrolled never entered the analytic cohort. Everyone had to be able to walk at least 10 feet with moderate assistance or less — which excludes some of the frailest older adults, precisely the people whose families might be most interested in the answer.

That leaves a wider question untouched. Whether walking intensity matters in the same way for a healthy 45-year-old, for someone with established heart disease, or for someone whose “brisk” is a slow pace behind a walker is something this trial simply does not address.

What “brisk” means — and why the word travels badly

CDC’s own guidance for measuring intensity puts a number on it: brisk walking means 2.5 miles per hour or faster. It also explains why that number is not portable. Intensity can be measured in relative terms — how hard the activity feels to the person doing it, where moderate effort is a 5 or 6 on a 0-to-10 scale and vigorous effort begins at 7 or 8 — or in absolute terms, where moderate activity burns 3 to 5.9 metabolic equivalents and vigorous activity 6.0 or more.

The CDC’s pages say the quiet part out loud: an activity that is vigorous for a person of average fitness may only be moderate for a very fit person. Run that logic backwards and it fits this trial. Seventy per cent of maximum heart rate for a 79-year-old with prefrailty is not the same physical experience as 70% for someone two decades younger and uninjured. The talk test — moderate effort means you can talk but not sing — is the same idea in plainer language.

Where this sits against public guidance

The volume targets have not changed. CDC’s age-group recommendations call for at least 150 minutes a week of moderate-intensity activity such as brisk walking for adults 18 to 64, plus muscle-strengthening activity on at least two days. For adults 65 and older it adds balance work, such as standing on one foot. The World Health Organization frames the same baseline globally and notes how far much of the world is from it: 31% of adults and 80% of adolescents do not meet recommended activity levels, a figure that has risen by five percentage points since 2010 and is projected to reach 35% of adults by 2030 if the trend holds. People who are insufficiently active carry a 20% to 30% higher risk of death than those who are sufficiently active, according to the same fact sheet.

Against that backdrop, the practical problem is rarely too little intensity. CDC estimates that only one in four US adults fully meets the guidelines for both aerobic and muscle-strengthening activity. It is a reasonable reading of the frailty trial that intensity is a second-order question after volume — a refinement for people who are already walking regularly, not a substitute for starting.

What we did not find

Nothing in this trial shows that walking faster extends life, prevents disease or protects against falls. Its outcomes are a frailty index category, a walking-speed measurement and a six-minute distance, all collected over 16 weeks in a supervised programme; no trial has connected walking pace in prefrail adults to mortality or to the health events that motivate the interest. Nor does it say anything about step counts, which were never measured here — the question of how daily steps and how hard those steps are taken combine is the subject of active research with different designs and different populations.

There is also a practical warning inside the finding. A programme that pushes heart rate to 70% of maximum, three supervised sessions a week for four months, is not a walking plan someone can safely improvise. The people in this trial were screened for mobility, walked with staff present, and were selected from a population already living in settings with support. For anyone who is frail, has a chronic condition, or has been inactive for a long stretch, the intensity question belongs in a conversation with a healthcare professional, not in a self-directed experiment.

This article reports what a published trial and public guidance say. It is information about a claim, not medical advice. Readers who want the broader picture of how activity is spread across a day can read our earlier look at the movement-break research, and the mechanics of attaching a new walk to an existing routine are set out in our piece on habit stacking.